| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SRRK | Common Stock | Sale | -$14M | -510K | -7.51% | $27.50* | 6.28M | Oct 7, 2024 | Samsara BioCapital, L.P. | F1, F2 |
| transaction | SRRK | Common Stock | Sale | -$15.3M | -510K | -8.12% | $30.00* | 5.77M | Oct 7, 2024 | By Samsara BioCapital, L.P. | F1, F2 |
| transaction | SRRK | Common Stock | Sale | -$5.06M | -156K | -2.7% | $32.50* | 5.61M | Oct 7, 2024 | By Samsara BioCapital, L.P. | F1, F2 |
| holding | SRRK | Common Stock | 13.5K | Oct 7, 2024 | Direct |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Samsara LP on June 10, 2024. |
| F2 | Shares held by Samsara BioCapital LP ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |